跳至主要内容
临床试验/ACTRN12613000026729
ACTRN12613000026729终止不适用

An investigation of the effects of intranasal oxytocin on socio-emotional brain regions in Huntington’s disease

Monash Biomedical Imaging0 个研究点目标入组 40 人开始时间: 2013年1月9日最近更新:

试验速览

阶段
不适用
状态
终止
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
25 Years 至 55 Years(—)
性别
Male

入选标准

  • For Healthy controls: Males; Right-handed; between the ages of 25-55 years; non-smoker and no drug/alcohol abuse; medication free; and no metal objects present in body (or which can't be removed or which is not MRI safe).
  • For Huntington's disease (HD): As above plus a diagnosis of the disease is required.

排除标准

  • Clinically significant medical or neurological condition (other than HD for the patients), significant head injury (or loss of consciousness from longer than 5 mins), presence of ferrous-containing metals within the body, inability to tolerate small enclosed spaces without anxiety.

研究者

发起方
Monash Biomedical Imaging

相似试验